Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jay Robert Harris, M.D.

Co-Author

This page shows the publications co-authored by Jay Harris and Jennifer Bellon.
Connection Strength

2.115
  1. What extent of radiation therapy is standard? Breast. 2005 Dec; 14(6):532-40.
    View in: PubMed
    Score: 0.318
  2. Chemotherapy and radiation therapy for breast cancer: what is the optimal sequence? J Clin Oncol. 2005 Jan 01; 23(1):5-7.
    View in: PubMed
    Score: 0.299
  3. The Impact of Reexcision and Residual Disease on Local Recurrence Following Breast-Conserving Therapy. Ann Surg Oncol. 2017 Jul; 24(7):1868-1873.
    View in: PubMed
    Score: 0.174
  4. Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy. Breast Cancer Res Treat. 2017 01; 161(1):173-179.
    View in: PubMed
    Score: 0.171
  5. Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat. 2013 Jul; 140(2):353-61.
    View in: PubMed
    Score: 0.136
  6. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol. 2011 Oct 10; 29(29):3885-91.
    View in: PubMed
    Score: 0.120
  7. The association between biological subtype and isolated regional nodal failure after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2010 May 01; 77(1):188-96.
    View in: PubMed
    Score: 0.107
  8. Internal mammary nodes in breast cancer: diagnosis and implications for patient management -- a systematic review. J Clin Oncol. 2008 Oct 20; 26(30):4981-9.
    View in: PubMed
    Score: 0.097
  9. Tangential radiotherapy without axillary surgery in early-stage breast cancer: results of a prospective trial. Int J Radiat Oncol Biol Phys. 2008 Nov 01; 72(3):866-70.
    View in: PubMed
    Score: 0.095
  10. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol. 2008 May 10; 26(14):2373-8.
    View in: PubMed
    Score: 0.095
  11. Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. Int J Radiat Oncol Biol Phys. 2007 Apr 01; 67(5):1299-308.
    View in: PubMed
    Score: 0.087
  12. A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1149-54.
    View in: PubMed
    Score: 0.083
  13. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol. 2005 Mar 20; 23(9):1934-40.
    View in: PubMed
    Score: 0.076
  14. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2005 Feb 01; 61(2):348-57.
    View in: PubMed
    Score: 0.076
  15. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma. Cancer. 2004 Apr 01; 100(7):1358-64.
    View in: PubMed
    Score: 0.071
  16. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2012 Mar 15; 82(4):e581-6.
    View in: PubMed
    Score: 0.031
  17. Can axillary node dissection be omitted in a subset of patients with low local and regional failure rates? Breast J. 2012 Jan-Feb; 18(1):23-7.
    View in: PubMed
    Score: 0.030
  18. Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):1185-91.
    View in: PubMed
    Score: 0.029
  19. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer. Int J Radiat Oncol Biol Phys. 2006 Feb 01; 64(2):496-504.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.